|
🐜
|
Cellular and molecular basis of pulmonary arterial hypertension.
12 auth.
N. Morrell,
S. Adnot,
S. Archer,
J. Dupuis,
Peter Lloyd Jones,
M. MacLean,
...
I. Mcmurtry,
K. Stenmark,
P. Thistlethwaite,
N. Weissmann,
J. Yuan,
E. Weir
|
9 |
2009 |
9
🐜
|
|
🐢
|
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.
10 auth.
S. Eddahibi,
M. Humbert,
E. Fadel,
B. Raffestin,
M. Darmon,
Frédérique Capron,
...
G. Simonneau,
P. Dartevelle,
Michel Hamon,
S. Adnot
|
9 |
2001 |
9
🐢
|
|
🐜
|
Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
19 auth.
Benoît Ranchoux,
F. Antigny,
C. Rucker-Martin,
A. Hautefort,
C. Péchoux,
H. Bogaard,
P. Dorfmüller,
S. Remy,
F. Lecerf,
Sylvie Planté,
...
S. Chat,
E. Fadel,
Amal Houssaini,
I. Anegon,
S. Adnot,
G. Simonneau,
M. Humbert,
S. Cohen-Kaminsky,
F. Perros
|
8 |
2015 |
8
🐜
|
|
🐜
|
Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
19 auth.
Benoît Ranchoux,
F. Antigny,
C. Rucker-Martin,
A. Hautefort,
C. Péchoux,
H. Bogaard,
P. Dorfmüller,
S. Remy,
F. Lecerf,
Sylvie Planté,
...
S. Chat,
E. Fadel,
Amal Houssaini,
I. Anegon,
S. Adnot,
G. Simonneau,
M. Humbert,
S. Cohen-Kaminsky,
F. Perros
|
8 |
2015 |
8
🐜
|
|
🐢
|
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.
7 auth.
S. Eddahibi,
N. Hanoun,
L. Lanfumey,
K. Lesch,
B. Raffestin,
M. Hamon,
...
S. Adnot
|
8 |
2000 |
8
🐢
|
|
🐢
|
Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease.
16 auth.
L. Savale,
A. Chaouat,
S. Bastuji‐Garin,
E. Marcos,
L. Boyer,
B. Maître,
M. Sarni,
B. Housset,
E. Weitzenblum,
M. Matrat,
...
P. Le Corvoisier,
D. Rideau,
J. Boczkowski,
J. Dubois-Randé,
C. Chouaid,
S. Adnot
|
8 |
2009 |
8
🐢
|
|
🐜
|
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
7 auth.
L. Savale,
L. Tu,
D. Rideau,
Mohamed Izziki,
B. Maître,
S. Adnot,
...
S. Eddahibi
|
8 |
2009 |
8
🐜
|
|
🐜
|
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
8 auth.
A. Hatzelmann,
E. Morcillo,
G. Lungarella,
S. Adnot,
S. Sanjar,
R. Beume,
...
C. Schudt,
H. Tenor
|
8 |
2010 |
8
🐜
|
|
🐢
|
5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension
M. Maclean,
P. Hervé,
S. Eddahibi,
S. Adnot
|
7 |
2000 |
7
🐢
|
|
🐜
|
Genetic basis of pulmonary arterial hypertension: current understanding and future directions.
16 auth.
J. Newman,
R. Trembath,
Jane A Morse,
E. Grunig,
J. Loyd,
S. Adnot,
F. Coccolo,
C. Ventura,
J. Phillips,
J. Knowles,
...
B. Janssen,
O. Eickelberg,
S. Eddahibi,
P. Herve,
W. Nichols,
G. Elliott
|
7 |
2004 |
7
🐜
|
|
🐢
|
Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
11 auth.
S. Eddahibi,
A. Chaouat,
N. Morrell,
E. Fadel,
C. Fuhrman,
A. Bugnet,
...
P. Dartevelle,
B. Housset,
M. Hamon,
E. Weitzenblum,
S. Adnot
|
7 |
2003 |
7
🐢
|
|
🐢
|
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
7 auth.
S. Eddahibi,
V. Fabre,
C. Boni,
M. Martres,
B. Raffestin,
M. Hamon,
...
S. Adnot
|
7 |
1999 |
7
🐢
|
